Ambee Pharmaceuticals PLC (DSE: AMBEEPHA)

Ambee Pharmaceuticals Revenue

Ambee Pharmaceuticals had revenue of 45.34M BDT in the quarter ending March 31, 2024, a decrease of -8.17%. This brings the company's revenue in the last twelve months to 205.24M, up 7.40% year-over-year. In the fiscal year ending June 30, 2023, Ambee Pharmaceuticals had annual revenue of 198.10M with 9.45% growth.

• Revenue (ttm): 205.24M
• Revenue Growth: +7.40%
• P/S Ratio: 8.43
• Revenue / Employee: 430.27K
• Employees: 477
• Market Cap: 1.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	198.10M	17.10M	9.45%
Jun 30, 2022	180.99M	82.02M	82.86%
Jun 30, 2021	98.98M	-186.33M	-65.31%
Jun 30, 2020	285.30M	-35.92M	-11.18%
Jun 30, 2019	321.22M	-28.16M	-8.06%